Christopher Missling
Company: Anavex
Job title: President & Chief Executive Officer
Seminars:
Uncovering Mitochondrial & Related Pathways for Parkinson’s Disease & Dementia to Discover Biomarkers 9:15 am
Analyzing various methods to discover pharmacodynamic biomarkers for Parkinson’s disease and dementia Identifying specific pathways that could outperform standard markers to overcome the transient nature of metabolic products Leveraging the genetic linkage of Parkinson’s disease and dementia with mitochondrial dysfunction to potentially trace back to the root cause of pathogenesisRead more
day: CONFERENCE DAY TWO
Panel Discussion: Translating Modality Into Value for Patients to Establish Clearly Defined Clinical Objectives 1:30 pm
Building on the industry’s failures to re-evaluate how to select and measure the right clinical outcome Steering the direction of research to acquire robust data that can illustrate clinical translatability and expedite discovery towards Phase I of clinical trials Positioning patients at the heart of the modality to demonstrate its viability, thereby eliminating the need…Read more
day: CONFERENCE DAY ONE